Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
Global Zanamivir Market Forecast 2025-2032: From USD 342.4 Million in 2024 to USD 484.8 Million Growth Outlook
Zanamivir, a potent neuraminidase inhibitor, remains a frontline defense in the global management of influenza. Marketed under the brand name Relenza, its role extends from seasonal outbreak control to national pandemic stockpiles. Following heightened global health awareness, the market is experiencing a strategic reassessment, projected to grow from USD 342.4 million in 2024 to USD 484.8...
0 Comments ·0 Shares ·187 Views
Please log in to like, share and comment!
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
VXEngine https://vxengine.ru